shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.

Xu, Ping

shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines. [electronic resource] - International journal of clinical and experimental pathology 2015 - 2300-10 p. digital

Publication Type: Journal Article

1936-2625


ATP Binding Cassette Transporter, Subfamily B--genetics
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Apoptosis Regulatory Proteins--metabolism
Breast Neoplasms--chemistry
Calcium-Binding Proteins--genetics
Cell Cycle Checkpoints--drug effects
Cell Cycle Proteins--metabolism
Cell Proliferation--drug effects
Cisplatin--pharmacology
Dose-Response Relationship, Drug
Doxorubicin--pharmacology
Drug Resistance, Neoplasm--genetics
Gene Expression Regulation, Neoplastic
Glioma--chemistry
Hep G2 Cells
Humans
Multidrug Resistance-Associated Proteins--genetics
Multiple Myeloma--drug therapy
RNA Interference
RNA, Small Interfering--genetics
Rhodamine 123--metabolism
Signal Transduction--drug effects
Transfection